Conditions and diseases
What is the clinical and cost effectiveness of cognitive rehabilitation for people with Multiple sclerosis (MS)?
Is intravenous methylprednisolone more clinically and cost effective than oral methylprednisolone in people with relapsing...
What is the optimal frequency, intensity and form of rehabilitation for mobility problems in people with Multiple Sclerosis (...
What non-pharmacological interventions are effective in reducing spasticity in people with Multiple Sclerosis (MS)?
Can vitamin D slow down the progression of disability in Multiple Sclerosis (MS)?
NICE encourages further research on percutaneous venoplasty for chronic cerebrospinal venous insufficiency (CCSVI) for multip...
NICE recommends the development of patient registries for multiple sclerosis to capture long-term treatment-related outcomes....
NICE recommends that a new model for multiple sclerosis is developed, ideally based on UK patient cohorts, which uses the bes...
NICE recommends further research to better inform future cost-effectiveness models of relapsing-remitting multiple sclerosis....
Supporting people with multiple sclerosis, who have limited mobility or are full-time wheelchair users, to remain physically active with the use of Oswestry standing frames
Separating Diagnostic Neurology from Management of Long-Term Neurological Conditions: A new concept of service delivery
Educating Healthcare Professionals about Functional Electrical Stimulation to improve patient care